Cargando…
Partial Response to Small Molecule Inhibition in a Case of Anaplastic Large Cell Lymphoma
In the era of personalized medicine, small-molecule inhibitors have become key to targeting many malignancies. Multiple hematologic malignancies are driven by small-molecule pathways that are seemingly ripe for such targeting. In this case report, we present a patient who was treated with a mitogen-...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050040/ https://www.ncbi.nlm.nih.gov/pubmed/35494913 http://dx.doi.org/10.7759/cureus.23627 |